These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 19811613)

  • 21. Anti-oxidant activities of curcumin and related enones.
    Weber WM; Hunsaker LA; Abcouwer SF; Deck LM; Vander Jagt DL
    Bioorg Med Chem; 2005 Jun; 13(11):3811-20. PubMed ID: 15863007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain.
    Bishnoi M; Chopra K; Kulkarni SK
    Pharmacol Biochem Behav; 2008 Feb; 88(4):511-22. PubMed ID: 18022680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-1beta-induced extracellular matrix degradation and glycosaminoglycan release is inhibited by curcumin in an explant model of cartilage inflammation.
    Clutterbuck AL; Mobasheri A; Shakibaei M; Allaway D; Harris P
    Ann N Y Acad Sci; 2009 Aug; 1171():428-35. PubMed ID: 19723086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemopreventive effects of embelin and curcumin against N-nitrosodiethylamine/phenobarbital-induced hepatocarcinogenesis in Wistar rats.
    Sreepriya M; Bali G
    Fitoterapia; 2005 Sep; 76(6):549-55. PubMed ID: 16009505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study on antifibrotic effects of curcumin in rat hepatic stellate cells.
    Lin YL; Lin CY; Chi CW; Huang YT
    Phytother Res; 2009 Jul; 23(7):927-32. PubMed ID: 19152370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB.
    Chiu J; Khan ZA; Farhangkhoee H; Chakrabarti S
    Nutrition; 2009 Sep; 25(9):964-72. PubMed ID: 19268536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production.
    Xie L; Li XK; Funeshima-Fuji N; Kimura H; Matsumoto Y; Isaka Y; Takahara S
    Int Immunopharmacol; 2009 May; 9(5):575-81. PubMed ID: 19539560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro curcumin modulates ferric nitrilotriacetate (Fe-NTA) and hydrogen peroxide (H2O2)-induced peroxidation of microsomal membrane lipids and DNA damage.
    Iqbal M; Okazaki Y; Okada S
    Teratog Carcinog Mutagen; 2003; Suppl 1():151-60. PubMed ID: 12616605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curcumin: getting back to the roots.
    Shishodia S; Sethi G; Aggarwal BB
    Ann N Y Acad Sci; 2005 Nov; 1056():206-17. PubMed ID: 16387689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Curcumin activates human glutathione S-transferase P1 expression through antioxidant response element.
    Nishinaka T; Ichijo Y; Ito M; Kimura M; Katsuyama M; Iwata K; Miura T; Terada T; Yabe-Nishimura C
    Toxicol Lett; 2007 May; 170(3):238-47. PubMed ID: 17449203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Preventive role of curcumin in lung cancer].
    Balcerek M; Matławska I
    Przegl Lek; 2005; 62(10):1180-1. PubMed ID: 16521985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kupffer cells are responsible for liver cirrhosis induced by carbon tetrachloride.
    Muriel P; Escobar Y
    J Appl Toxicol; 2003; 23(2):103-8. PubMed ID: 12666154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis.
    Camacho-Barquero L; Villegas I; Sánchez-Calvo JM; Talero E; Sánchez-Fidalgo S; Motilva V; Alarcón de la Lastra C
    Int Immunopharmacol; 2007 Mar; 7(3):333-42. PubMed ID: 17276891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TPA-induced up-regulation of activator protein-1 can be inhibited or enhanced by analogs of the natural product curcumin.
    Weber WM; Hunsaker LA; Gonzales AM; Heynekamp JJ; Orlando RA; Deck LM; Vander Jagt DL
    Biochem Pharmacol; 2006 Oct; 72(8):928-40. PubMed ID: 16934760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beneficial drugs for liver diseases.
    Muriel P; Rivera-Espinoza Y
    J Appl Toxicol; 2008 Mar; 28(2):93-103. PubMed ID: 17966118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Curcumin as "Curecumin": from kitchen to clinic.
    Goel A; Kunnumakkara AB; Aggarwal BB
    Biochem Pharmacol; 2008 Feb; 75(4):787-809. PubMed ID: 17900536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of lipid peroxidation and cholesterol levels in mice by curcumin.
    Soudamini KK; Unnikrishnan MC; Soni KB; Kuttan R
    Indian J Physiol Pharmacol; 1992 Oct; 36(4):239-43. PubMed ID: 1291474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of the renin-angiotensin system attenuates the development of liver fibrosis and oxidative stress in rats.
    El-Demerdash E; Salam OM; El-Batran SA; Abdallah HM; Shaffie NM
    Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):159-67. PubMed ID: 17900296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curcumin in Hepatobiliary Disease: Pharmacotherapeutic Properties and Emerging Potential Clinical Applications.
    Hu RW; Carey EJ; Lindor KD; Tabibian JH
    Ann Hepatol; 2017 November-December,; 16(6):835-841. PubMed ID: 29055920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunomodulatory effect of curcumin on hepatic cirrhosis in experimental rats.
    Abo-Zaid MA; Shaheen ES; Ismail AH
    J Food Biochem; 2020 Jun; 44(6):e13219. PubMed ID: 32215945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.